Xiangyu Chen

机构：Harbin Medical University, Guangdong Pharmaceutical University, Beijing Normal University, First Affiliated Hospital of Harbin Medical University, Heilongjiang University · ORCID：0000-0002-5387-8621

发表论文 12 篇 · 总被引 375 次 · h-index 9

代表论文

Diosmetin alleviated cerebral ischemia/reperfusion injury in vivo and in vitro by inhibiting oxidative stress via the SIRT1/Nrf2 signaling pathway (2021 · Food & Function · 被引 85)
No-reflow after recanalization in ischemic stroke: From pathomechanisms to therapeutic strategies (2024 · Journal of Cerebral Blood Flow & Metabolism · 被引 69)
Mitochondrial quality control in stroke: From the mechanisms to therapeutic potentials (2022 · Journal of Cellular and Molecular Medicine · 被引 65)
The Interplay between Mitochondrial Dysfunction and Ferroptosis during Ischemia-Associated Central Nervous System Diseases (2023 · Brain Sciences · 被引 49)
Astragaloside IV combined with ligustrazine ameliorates abnormal mitochondrial dynamics via Drp1 SUMO / deSUMOylation in cerebral ischemia–reperfusion injury (2024 · CNS Neuroscience & Therapeutics · 被引 37)
An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury (2021 · Drug Design Development and Therapy · 被引 30)